AUTHOR=Liao Jun , Fu Qian , Chen Wenfang , Li Jun , Zhang Wenhui , Zhang Huanxi , Gao Yifang , Yang Shicong , Xu Bowen , Huang Huiting , Wang Jiali , Li Xirui , Liu Longshan , Wang Changxi TITLE=Plasma Soluble CD146 as a Potential Diagnostic Marker of Acute Rejection in Kidney Transplantation JOURNAL=Frontiers in Medicine VOLUME=7 YEAR=2020 URL=https://www.frontiersin.org/journals/medicine/articles/10.3389/fmed.2020.531999 DOI=10.3389/fmed.2020.531999 ISSN=2296-858X ABSTRACT=
Previous studies have implicated the role of CD146 and its soluble form (sCD146) in the pathogenesis of inflammatory diseases. However, the association between CD146 and acute rejection in kidney transplant patients remains unexplored. In this study, fifty-six patients with biopsy-proved rejection or non-rejection and 11 stable allograft function patients were retrospectively analyzed. Soluble CD146 in plasma was detected in peripheral blood by enzyme linked immunosorbent assay (ELISA), and local CD146 expression in graft biopsy was detected by immunohistochemistry. We found that plasma soluble CD146 in acute rejection recipients was significantly higher than in stable patients without rejection, and the biopsy CD146 staining in the rejection group was higher than that of the non-rejection group. Multivariate analysis demonstrated soluble CD146 as an independent risk factor of acute rejection. The area under the receiver operating characteristic curve (AUC) of sCD146 for AR diagnosis was 0.895, and the optimal cut-off value was 75.64 ng/ml, with a sensitivity of 87.8% and a specificity of 80.8%, which was better than eGFR alone (